case_images: PMC3469074_01
case_images: Abdominal mass biopsy showing mesothelioma (H&E, low power).
case_images: CRIM.ONCMED2012-619348.001.jpg
case_images: PMC3469074_01_CRIM.ONCMED2012-619348.001.jpg
case_images: fig1
case_images: D240, and negative for CEA and MOC31 (Figures 1, 2, 3, 4, and 5). Due to the extension of his disease, it was considered nonresectable.
case_images: Mesothelioma (H&E, high power).
case_images: CRIM.ONCMED2012-619348.002.jpg
case_images: PMC3469074_01_CRIM.ONCMED2012-619348.002.jpg
case_images: fig2
case_images: D240, and negative for CEA and MOC31 (Figures 1, 2, 3, 4, and 5). Due to the extension of his disease, it was considered nonresectable.
case_images: Immunohistochemistry showing calretinin-positive cells.
case_images: CRIM.ONCMED2012-619348.003.jpg
case_images: PMC3469074_01_CRIM.ONCMED2012-619348.003.jpg
case_images: fig3
case_images: D240, and negative for CEA and MOC31 (Figures 1, 2, 3, 4, and 5). Due to the extension of his disease, it was considered nonresectable.
case_images: Immunohistochemistry showing cytokeratin-positive cells.
case_images: CRIM.ONCMED2012-619348.004.jpg
case_images: PMC3469074_01_CRIM.ONCMED2012-619348.004.jpg
case_images: fig4
case_images: D240, and negative for CEA and MOC31 (Figures 1, 2, 3, 4, and 5). Due to the extension of his disease, it was considered nonresectable.
case_images: Immunohistochemistry showing D240-positive cells.
case_images: CRIM.ONCMED2012-619348.005.jpg
case_images: PMC3469074_01_CRIM.ONCMED2012-619348.005.jpg
case_images: fig5
case_images: D240, and negative for CEA and MOC31 (Figures 1, 2, 3, 4, and 5). Due to the extension of his disease, it was considered nonresectable.